RESUMEN
Interferometric gravitational wave detectors operate with high optical power in their arms in order to achieve high shot-noise limited strain sensitivity. A significant limitation to increasing the optical power is the phenomenon of three-mode parametric instabilities, in which the laser field in the arm cavities is scattered into higher-order optical modes by acoustic modes of the cavity mirrors. The optical modes can further drive the acoustic modes via radiation pressure, potentially producing an exponential buildup. One proposed technique to stabilize parametric instability is active damping of acoustic modes. We report here the first demonstration of damping a parametrically unstable mode using active feedback forces on the cavity mirror. A 15 538 Hz mode that grew exponentially with a time constant of 182 sec was damped using electrostatic actuation, with a resulting decay time constant of 23 sec. An average control force of 0.03 nN was required to maintain the acoustic mode at its minimum amplitude.
RESUMEN
This paper presents an analysis of the transient behavior of the Advanced LIGO (Laser Interferometer Gravitational-wave Observatory) suspensions used to seismically isolate the optics. We have characterized the transients in the longitudinal motion of the quadruple suspensions during Advanced LIGO's first observing run. Propagation of transients between stages is consistent with modeled transfer functions, such that transient motion originating at the top of the suspension chain is significantly reduced in amplitude at the test mass. We find that there are transients seen by the longitudinal motion monitors of quadruple suspensions, but they are not significantly correlated with transient motion above the noise floor in the gravitational wave strain data, and therefore do not present a dominant source of background noise in the searches for transient gravitational wave signals. Using the suspension transfer functions, we compared the transients in a week of gravitational wave strain data with transients from a quadruple suspension. Of the strain transients between 10 and 60 Hz, 84% are loud enough that they would have appeared above the sensor noise in the top stage quadruple suspension monitors if they had originated at that stage at the same frequencies. We find no significant temporal correlation with the suspension transients in that stage, so we can rule out suspension motion originating at the top stage as the cause of those transients. However, only 3.2% of the gravitational wave strain transients are loud enough that they would have been seen by the second stage suspension sensors, and none of them are above the sensor noise levels of the penultimate stage. Therefore, we cannot eliminate the possibility of transient noise in the detectors originating in the intermediate stages of the suspension below the sensing noise.
RESUMEN
BACKGROUND: Gut hormones change with weight loss in adults but are not well studied in obese youth. OBJECTIVE: The primary aim was to evaluate how gut hormones and subjective appetite measure change with dietary weight loss in obese adolescents. METHODS: Participants were a subset of those taking part in the 'Eat Smart Study'. They were aged 10-17 years with body mass index (BMI) > 90th centile and were randomized to one of three groups: wait-listed control, structured reduced carbohydrate or structured low-fat dietary intervention for 12 weeks. Outcomes were fasting glucose, insulin, leptin, adiponectin, total amylin, acylated ghrelin, active glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide (GIP), pancreatic polypeptide (PP) and total peptide tyrosine-tyrosine. Pre- and postprandial subjective sensations of appetite were assessed using visual analogue scales. RESULTS: Of 87 'Eat Smart' participants, 74 participated in this sub-study. The mean (standard deviation) BMIâ z-score was 2.1 (0.4) in the intervention groups at week 12 compared with 2.2 (0.4) in the control group. Fasting insulin (P = 0.05) and leptin (P = 0.03) levels decreased, while adiponectin levels increased (P = 0.05) in the intervention groups compared with control. The intervention groups were not significantly different from each other. A decrease in BMIâ z-score at week 12 was associated with decreased fasting insulin (P < 0.001), homeostatic model of assessment-insulin resistance (P < 0.001), leptin (P < 0.001), total amylin (P = 0.03), GIP (P = 0.01), PP (P = 0.02) and increased adiponectin (P < 0.001). There was no significant difference in appetite sensations. CONCLUSIONS: Modest weight loss in obese adolescents leads to changes in some adipokines and gut hormones that may favour weight regain.
Asunto(s)
Polipéptido Inhibidor Gástrico/metabolismo , Ghrelina/metabolismo , Obesidad Infantil/metabolismo , Adiponectina/metabolismo , Adolescente , Adulto , Apetito , Índice de Masa Corporal , Peso Corporal , Ayuno/metabolismo , Femenino , Péptido 1 Similar al Glucagón/metabolismo , Humanos , Insulina/metabolismo , Resistencia a la Insulina , Leptina/metabolismo , Masculino , Péptido YY/metabolismo , Periodo Posprandial , Pérdida de PesoRESUMEN
Cosmic strings can give rise to a large variety of interesting astrophysical phenomena. Among them, powerful bursts of gravitational waves (GWs) produced by cusps are a promising observational signature. In this Letter we present a search for GWs from cosmic string cusps in data collected by the LIGO and Virgo gravitational wave detectors between 2005 and 2010, with over 625 days of live time. We find no evidence of GW signals from cosmic strings. From this result, we derive new constraints on cosmic string parameters, which complement and improve existing limits from previous searches for a stochastic background of GWs from cosmic microwave background measurements and pulsar timing data. In particular, if the size of loops is given by the gravitational backreaction scale, we place upper limits on the string tension Gµ below 10(-8) in some regions of the cosmic string parameter space.
RESUMEN
BACKGROUND: A study was undertaken to observe the gains in bone mass in children and adolescents with cystic fibrosis (CF) over 24 months and to examine the relationship between areal bone mineral density (aBMD) and associated clinical parameters including physical activity, nutrition, and 25-hydroxyvitamin D (25OHD). METHODS: Areal BMD of the total body (TB), lumbar spine (LS), and total femoral neck (FNt) were repeatedly measured in 85 subjects aged 5-18 years with CF and 100 age and sex matched controls over 2 years. At each visit anthropometric variables, nutritional parameters, pubertal status, disease severity, physical activity, dietary calcium, caloric intake, and serum 25OHD were assessed and related to aBMD. RESULTS: After adjusting for age, sex, and height Z-score, gains in LS aBMD in children (5-10 years) and TB and FNt aBMD in adolescents (11-18 years) with CF were significantly less than in controls. Lean tissue mass was significantly associated with TB and LS aBMD gains in children and adolescents and explained a significant proportion of the aBMD deficit observed. Lung function parameters were significantly associated with aBMD gains in adolescents with CF. CONCLUSIONS: Inadequate bone mass accrual during childhood and adolescence contributes to the low bone mass observed in adults with CF. Accounting for the height discrepancy which is frequently observed in those with CF, in addition to age and sex, is important when assessing low bone mass in children and adolescents with CF. To optimise an individual's potential to acquire maximal bone mass, it is necessary to maximise nutritional status and limit the progression of chronic suppurative lung disease.
Asunto(s)
Densidad Ósea/fisiología , Fibrosis Quística/fisiopatología , Adolescente , Factores de Edad , Estudios de Casos y Controles , Niño , Preescolar , Femenino , Cuello Femoral , Volumen Espiratorio Forzado/fisiología , Humanos , Estudios Longitudinales , Vértebras Lumbares , Masculino , Caracteres Sexuales , Capacidad Vital/fisiologíaRESUMEN
OBJECTIVES: To describe the glycaemic status (assessed by an oral glucose tolerance test (OGTT)) and associated comorbidities in a cohort of Australian children and adolescents at risk of insulin resistance and impaired glucose homeostasis (IGH). METHODS: Twenty-one children and adolescents (three male, 18 female) (18 Caucasian, one Indigenous, two Asian) (20 obese, one lipodystrophy) referred to the Paediatric Endocrinology and Diabetes Clinic underwent a 2-h OGTT with plasma glucose and insulin measured at baseline, + 60 and + 120 min. If abnormal, the OGTT was repeated. RESULTS: The mean (SD) age was 14.2 (1.6) years, BMI 38.8 (7.0) kg/m2 and BMI-SDS 3.6 (0.6). Fourteen patients had fasting insulin levels >21 mU/L. Type 2 diabetes mellitus was diagnosed in one patient, impaired glucose tolerance (IGT) in four patients and impaired fasting glycaemia (IFG) in one patient. Despite no weight loss, only one patient had a persistently abnormal OGTT on repeat testing. Three patients with IGH were medicated with risperidone at the time of the initial OGTT. One patient who had persistent IGT had continued risperidone. The other two patients had initial OGTT results of IGT and diabetes mellitus type 2. They both ceased risperidone between tests and repeat OGTT showed normal glycaemic status. CONCLUSIONS: Use of fasting glucose alone may miss cases of IGH. Diagnosis of IGT should not be made on one test alone. Interpretation of glucose and insulin responses in young people is limited by lack of normative data. Larger studies are needed to generate Australian screening recommendations. Further assessment of the potential adverse effects of atypical antipsychotic medication on glucose homeostasis in this at-risk group is important.
Asunto(s)
Glucemia/metabolismo , Trastornos del Metabolismo de la Glucosa/diagnóstico , Insulina/metabolismo , Obesidad/complicaciones , Adolescente , Niño , Estudios de Cohortes , Diagnóstico Diferencial , Femenino , Trastornos del Metabolismo de la Glucosa/sangre , Trastornos del Metabolismo de la Glucosa/etiología , Prueba de Tolerancia a la Glucosa/métodos , Índice Glucémico , Humanos , Resistencia a la Insulina , Masculino , Obesidad/sangre , Queensland , Factores de RiesgoRESUMEN
A case of a 9-year-old female with suprasternal extension of the thymus mimicking thyroid gland enlargement is described. Ultrasonography successfully established the diagnosis. Aberrant cervical thymic tissue is an infrequently reported cause of paediatric neck masses. It is important to be aware of this entity to prevent anxiety and inappropriate investigation and/or intervention.
Asunto(s)
Coristoma/diagnóstico , Timo , Enfermedades de la Tiroides/diagnóstico , Niño , Diagnóstico Diferencial , Femenino , HumanosRESUMEN
Abnormalities in the growth plate may lead to short stature and skeletal deformity including Leri Weil syndrome, which has been shown to result from deletions or mutations in the SHOX gene, a homeobox gene located at the pseudoautosomal region of the X and Y chromosome. We studied the expression of SHOX protein, by immunohistochemistry, in human fetal and childhood growth plates and mRNA by in situ hybridization in childhood normal and Leri Weil growth plate. SHOX protein was found in reserve, proliferative, and hypertrophic zones of fetal growth plate from 12 wk to term and childhood control and Leri Weil growth plates. The pattern of immunostaining in the proliferative zone of childhood growth plate was patchy, with more intense uniform immunostaining in the hypertrophic zone. In situ hybridization studies of childhood growth plate demonstrated SHOX mRNA expression throughout the growth plate. No difference in the pattern of SHOX protein or mRNA expression was seen between the control and Leri Weil growth plate. These findings suggest that SHOX plays a role in chondrocyte function in the growth plate.
Asunto(s)
Placa de Crecimiento/embriología , Placa de Crecimiento/metabolismo , Proteínas de Homeodominio/metabolismo , Adolescente , Niño , Femenino , Proteínas de Homeodominio/genética , Humanos , Inmunohistoquímica , Hibridación in Situ , Masculino , Biología Molecular , ARN Mensajero/metabolismo , Proteína de la Caja Homeótica de Baja EstaturaRESUMEN
BACKGROUND: Low bone mineral density (BMD) is recognised in individuals with cystic fibrosis (CF) although the pathogenesis remains unclear. The aims of this study were to compare BMD over a broad continuum of Australian individuals with CF with healthy controls and to examine the relationship between BMD and clinical parameters including physical activity, nutrition, and vitamin D levels. METHODS: BMD of the lumbar spine (LS), total body (TB), femoral neck (FN), cortical wrist (R33%), and distal wrist (RUD) was examined in 153 individuals with CF aged 5.3-55.8 years (84 males) and in 149 local controls aged 5.6-48.3 years (66 males) using dual energy x ray absorptiometry. Anthropometric variables, body cell mass, markers of disease severity, corticosteroid usage, measures of physical activity, dietary calcium and caloric intake and serum vitamin D were assessed and related to BMD. RESULTS: Compared with controls, mean BMD was not significantly different in children aged 5-10 years with CF. Adolescents (females 11-18 years, males 11-20 years) had reduced TB and R33% BMD when adjusted for age, sex, and height (difference in BMD (g/cm2) adjusted means between control and CF: TB=0.04 (95% CI 0.01 to 0.07); R33%=0.03 (95% CI 0.01 to 0.06)). BMD was reduced at all sites except R33% in adults (difference in BMD (g/cm2) adjusted means between control and CF: TB=0.05 (95% CI 0.02 to 0.09); LS=0.08 (95% CI 0.03 to 0.14); FN=0.09 (95% CI 0.03 to 0.15); RUD=0.03 (95% CI 0.01 to 0.05)). In children/adolescents BMD was weakly associated with nutritional status and disease severity. CONCLUSIONS: BMD was normal in a well nourished group of prepubertal children with CF. A BMD deficit appears to evolve during adolescence and becomes more marked in adults. Individuals with CF should optimise nutrition, partake in physical activity, and maximise lung health in order to optimise BMD. Further longitudinal studies are required to understand the evolution of reduced BMD in young people and adults with CF.
Asunto(s)
Densidad Ósea/fisiología , Fibrosis Quística/fisiopatología , Adolescente , Corticoesteroides/efectos adversos , Adulto , Calcio de la Dieta/administración & dosificación , Niño , Preescolar , Estudios Transversales , Suplementos Dietéticos , Ejercicio Físico , Femenino , Fracturas Óseas/etiología , Humanos , Masculino , Persona de Mediana Edad , Queensland , Vitamina D/administración & dosificaciónRESUMEN
A 13 year-old girl with clinical features of Addison's disease developed acute cardiac failure after initiation of treatment and after initial clinical improvement. Large doses of i.v. hydrocortisone and oral fludrocortisone, in addition to inotropic and ventilatory support, were required to achieve cardiovascular stability. The cardiomyopathy improved over one week and her condition then remained stable on oral glucocorticoid and mineralocorticoid replacement therapy. Reversible cardiomyopathy is a rare and potentially life-threatening complication of Addison's disease. The second reported paediatric patient is presented, the only one reported to require ventilatory support.
Asunto(s)
Enfermedad de Addison/complicaciones , Cardiomiopatía Dilatada/complicaciones , Cardiomiopatía Dilatada/tratamiento farmacológico , Enfermedad de Addison/diagnóstico , Enfermedad de Addison/tratamiento farmacológico , Administración Oral , Adolescente , Australia , Cardiomiopatía Dilatada/diagnóstico , Cardiotónicos/uso terapéutico , Dobutamina/farmacología , Dobutamina/uso terapéutico , Dopamina/farmacología , Dopamina/uso terapéutico , Esquema de Medicación , Ecocardiografía , Femenino , Fludrocortisona/administración & dosificación , Fludrocortisona/uso terapéutico , Fluidoterapia , Humanos , Hidrocortisona/administración & dosificación , Hidrocortisona/uso terapéutico , Inyecciones Intravenosas , Factores de Tiempo , Resultado del TratamientoRESUMEN
Leri-Weill syndrome (LWS) is a skeletal dysplasia with mesomelic short stature, bilateral Madelung deformity (BMD) and SHOX (short stature homeobox-containing gene) haploinsufficiency. The effect of 24 months of recombinant human growth hormone (rhGH) therapy on the stature and BMD of two females with SHOX haploinsufficiency (demonstrated by fluorescence in situ hybridisation) and LWS was evaluated. Both patients demonstrated an increase in height standard deviation score (SDS) and height velocity SDS over the 24 months of therapy. Patient 1 demonstrated a relative increase in arm-span and upper segment measurements with rhGH while patient 2 demonstrated a relative increase in lower limb length. There was appropriate advancement of bone age, no adverse events and no significant deterioration in BMD. In this study, 24 months of rhGH was a safe and effective therapy for the disproportionate short stature of SHOX haploinsufficiency, with no clinical deterioration of BMD.
Asunto(s)
Estatura/efectos de los fármacos , Estatura/genética , Trastornos del Crecimiento/tratamiento farmacológico , Trastornos del Crecimiento/genética , Hormona del Crecimiento/uso terapéutico , Proteínas de Homeodominio/genética , Adolescente , Brazo/anatomía & histología , Brazo/crecimiento & desarrollo , Huesos/diagnóstico por imagen , Niño , Femenino , Mano/diagnóstico por imagen , Haplotipos , Humanos , Hibridación Fluorescente in Situ , Cariotipificación , Pierna/anatomía & histología , Pierna/crecimiento & desarrollo , Masculino , Fenotipo , Radiografía , Proteína de la Caja Homeótica de Baja EstaturaRESUMEN
This study was designed to determine the intrafamilial effect of SHOX haploinsufficiency on stature, by comparing the growth and phenotype of 26 SHOX haploinsufficient individuals with 45 relatives and population standards. It confirmed that SHOX haploinsufficiency leads to growth restriction from birth to final height. Compared to unaffected siblings, the SHOX haploinsufficient cohort was 2.14 SDS (3.8 cm) shorter at birth and 2.1 SDS shorter through childhood. At final height females were 2.4 SDS (14.4 cm) shorter and males 0.8 SDS (5.3 cm) shorter than normal siblings. The family height analysis suggests that the effect of SHOX haploinsufficiency on growth may have been previously underestimated at birth and overestimated in males at final height. SHOX haploinsufficiency leads to short arms in 92%, bilateral Madelung deformity in 73% and short stature in 54%. Females were more severely affected than males. We conclude that SHOX is a major growth gene and that mutations are associated with a broad range of phenotype.
Asunto(s)
Desarrollo Óseo/genética , Trastornos del Crecimiento/genética , Crecimiento/genética , Proteínas de Homeodominio/genética , Adolescente , Adulto , Determinación de la Edad por el Esqueleto , Anciano , Brazo/anatomía & histología , Brazo/crecimiento & desarrollo , Estatura/genética , Estatura/fisiología , Densidad Ósea/genética , Densidad Ósea/fisiología , Huesos/diagnóstico por imagen , Niño , Estudios de Cohortes , Femenino , Genotipo , Haplotipos , Humanos , Recién Nacido , Pierna/anatomía & histología , Pierna/crecimiento & desarrollo , Masculino , Persona de Mediana Edad , Linaje , Fenotipo , Proteína de la Caja Homeótica de Baja Estatura , SíndromeRESUMEN
Congenital and acquired forms of osteoporosis in childhood and adolescence can result in morbidity from fracture and pain in childhood, and place an individual at significant risk for problems in adult life. A range of therapies exist for the prevention and treatment of osteoporosis, including optimization of daily calcium intake, adequate vitamin D status, weight-bearing exercise, treatment with sex steroids where delayed puberty is a problem and, more recently, use of bisphosphonate therapy. Intravenous pamidronate therapy (a bisphosphonate) has been shown to reduce fractures and improve bone density in children with osteogenesis imperfecta, and might prove to be of benefit in other osteoporotic conditions in childhood. However, a number of issues regarding the optimal use of bisphosphonate therapy in children and adolescents remain to be resolved, including total annual dose and frequency and duration of administration. Bisphosphonate therapy should, therefore, be used only in the context of a well-run clinical programme with specialist knowledge in the management of osteopenic disorders in childhood.
Asunto(s)
Difosfonatos/uso terapéutico , Osteoporosis/diagnóstico , Osteoporosis/tratamiento farmacológico , Absorciometría de Fotón , Adolescente , Densidad Ósea , Niño , Preescolar , Difosfonatos/efectos adversos , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Estudios de Seguimiento , Humanos , Masculino , Medición de Riesgo , Índice de Severidad de la Enfermedad , Resultado del TratamientoAsunto(s)
Estatura/genética , Genes Homeobox/genética , Proteínas de Homeodominio/genética , Mutación/genética , Osteocondrodisplasias/genética , Estudios de Cohortes , Femenino , Trastornos del Crecimiento/epidemiología , Trastornos del Crecimiento/genética , Humanos , Masculino , Osteocondrodisplasias/epidemiología , Linaje , Prevalencia , Proteína de la Caja Homeótica de Baja Estatura , SíndromeRESUMEN
The Turner syndrome (TS) is a complex disorder associated with almost invariant short stature and gonadal dysgenesis, as well as a variety of other major organ malformations. Recently, a homeobox-containing gene entitled short-stature homeobox-containing gene (SHOX), was isolated from a minimal short stature gene interval from the pseudoautosomal region of Xp (and Yp). Together with the demonstrable escape of SHOX from X-inactivation, this suggested SHOX to be a strong candidate gene for the short stature component of TS, and as SHOX haploinsufficiency appears to be the molecular basis of a mesomelic short statured skeletal dysplasia (Leri-Weill syndrome), this suggested that SHOX protein expression levels may confer a dosage effect on human stature. However, in this communication we report a normal statured female with gonadal dysgenesis, due to the inheritance of a recombinant duplication-deletion X-chromosome. The karyotype of the proband was 46,X,rec(X)dup(Xp)inv(X)(p11.22q21.2)mat and fluorescent in situ hybridization of her metaphases with a SHOX cosmid confirmed the proband to be trisomic for SHOX. This communication suggests the relationship between levels of SHOX expression and human stature to be more complex than envisaged previously. The presence of normal stature in our patient rather than tall stature is likely to represent the natural variation seen in patients with transcription factor disorders.
Asunto(s)
Estatura/genética , Disgenesia Gonadal 46 XX/genética , Proteínas de Homeodominio/genética , Trisomía , Cromosoma X/genética , Adolescente , Compensación de Dosificación (Genética) , Terapia de Reemplazo de Estrógeno , Femenino , Disgenesia Gonadal 46 XX/tratamiento farmacológico , Humanos , Hibridación Fluorescente in Situ , Proteína de la Caja Homeótica de Baja EstaturaRESUMEN
In humans, low peak bone mass is a significant risk factor for osteoporosis. We report that LRP5, encoding the low-density lipoprotein receptor-related protein 5, affects bone mass accrual during growth. Mutations in LRP5 cause the autosomal recessive disorder osteoporosis-pseudoglioma syndrome (OPPG). We find that OPPG carriers have reduced bone mass when compared to age- and gender-matched controls. We demonstrate LRP5 expression by osteoblasts in situ and show that LRP5 can transduce Wnt signaling in vitro via the canonical pathway. We further show that a mutant-secreted form of LRP5 can reduce bone thickness in mouse calvarial explant cultures. These data indicate that Wnt-mediated signaling via LRP5 affects bone accrual during growth and is important for the establishment of peak bone mass.
Asunto(s)
Densidad Ósea/genética , Anomalías del Ojo/genética , Ojo/embriología , Osteoblastos/metabolismo , Osteoporosis/genética , Receptores de LDL/fisiología , Factor de Crecimiento Transformador beta , Proteínas de Pez Cebra , Proteínas Adaptadoras Transductoras de Señales , Adulto , Animales , Animales no Consanguíneos , Proteína Morfogenética Ósea 2 , Proteínas Morfogenéticas Óseas/farmacología , Células COS , Niño , Preescolar , Chlorocebus aethiops , Cromosomas Humanos Par 11/genética , Medios de Cultivo Condicionados/farmacología , ADN Complementario/genética , Proteínas Dishevelled , Femenino , Genes Recesivos , Heterocigoto , Humanos , Proteínas Relacionadas con Receptor de LDL , Proteína-5 Relacionada con Receptor de Lipoproteína de Baja Densidad , Masculino , Mesodermo/citología , Ratones , Ratones Endogámicos C57BL , Técnicas de Cultivo de Órganos , Fosfoproteínas/genética , Fosfoproteínas/fisiología , Proteínas/genética , Proteínas/fisiología , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas/fisiología , Receptores de LDL/deficiencia , Receptores de LDL/genética , Proteínas Recombinantes de Fusión/fisiología , Proteínas Recombinantes , Transducción de Señal , Cráneo/citología , Especificidad de la Especie , Células del Estroma/citología , Células del Estroma/efectos de los fármacos , Síndrome , Transfección , Proteínas Wnt , Proteína Wnt-5a , Proteína wnt2 , Proteína Wnt3 , Proteína Wnt4RESUMEN
We tested the hypothesis that X-linked genes determining stature which are subject to skewed or non-random X-inactivation can account for discordance in height in monozygotic female twins. Height discordant female monozygotic adult twins (20 pairs) were identified from the Australian Twin Registry, employing the selection criteria of proven monozygosity and a measured height discordance of at least 5 cm. Differential X-inactivation was examined in genomic DNA extracted from peripheral lymphocytes by estimating differential methylation of alleles at the polymorphic CAG triplet repeat of the Androgen receptor gene (XAR). There were 17/20 MZ pairs heterozygous at this locus and informative for analysis. Of these, 10/17 both had random X-inactivation, 5/17 showed identical X-inactivation patterns of non random inactivation and 2/17 (12%) showed discordant X-inactivation. There was no relationship between inactivation patterns and self-report chorionicity. We conclude that non-random X-inactivation does not appear to be a major contributor to intra-pair height discordance in female MZ twins.
Asunto(s)
Estatura/genética , Compensación de Dosificación (Genética) , Ligamiento Genético/genética , Sistema de Registros , Gemelos Monocigóticos/genética , Adulto , Estudios de Cohortes , Desoxirribonucleasa HpaII , Femenino , Humanos , Reacción en Cadena de la Polimerasa , Factores Sexuales , Repeticiones de Trinucleótidos/genética , Estudios en Gemelos como AsuntoRESUMEN
Leri-Weill syndrome (LWS) is a dominant (pseudoautosomal) skeletal dysplasia with mesomelic short stature and bilateral Madelung deformity, due to dyschondrosteosis of the distal radius. It results from the loss of one copy of the Short Stature Homeobox Gene (SHOX) from the tip of the short arm of the X or Y chromosome. SHOX molecular testing enabled us to evaluate the histopathology of the radial physis in LWS patients with a documented SHOX abnormality. A widespread disorganisation of physeal anatomy was revealed with disruption of the normal parallel columnar arrangement of chondrocytes. Tandem stacking of maturing chondrocytes within columns was replaced by a side-by-side arrangement. The presence of hypertrophic osteoid with micro-enchondromata in the radial metaphysis suggests abnormal endochondral ossification. The Vickers' ligament was confirmed to blend with the triangular fibrocartilage complex (TFCC). This histopathological study demonstrates that the zone of dyschondrosteosis in LWS is characterised by marked disruption of normal physeal chondrocyte processes and that a generalised physeal abnormality is present.
Asunto(s)
Placa de Crecimiento/patología , Proteínas de Homeodominio/genética , Osteocondrodisplasias/patología , Osteocondrodisplasias/cirugía , Radio (Anatomía)/anomalías , Adolescente , Estatura , Niño , Aberraciones Cromosómicas , Femenino , Estudios de Seguimiento , Humanos , Mutación , Osteocondrodisplasias/genética , Radio (Anatomía)/cirugía , Rango del Movimiento Articular , Proteína de la Caja Homeótica de Baja Estatura , Resultado del Tratamiento , Articulación de la Muñeca/fisiopatologíaRESUMEN
OBJECTIVE: To review the common clinical presentations, investigations and final diagnosis of children presenting with genital ambiguity. METHODOLOGY: Retrospective search of the Royal Children's Hospital, Brisbane, Australia, medical records and personal medical database of one of the authors (MJT) between 1982 and 1999. RESULTS: Fifty-one children aged 0.1-14 (mean 3.9) years were identified. Twenty-two cases had a 46XX karyotype, and commonly presented with an enlarged phallus (77.2%), urogenital sinus (63.6%) and labioscrotal fold(s) (40.9%). Congenital adrenal hyperplasia (CAH) was the most common final diagnosis (72.7%). Twenty-nine cases of genital ambiguity had a 46XY karyotype and commonly presented with palpable gonad(s) (75.8%), undescended testes (51.7%), penoscrotal hypospadias (51.7%) and a small phallus (41.3%). Androgen insensitivity and gonadal dysgenesis were the commonest final diagnosis both occurring at a frequency of 17.2%. CONCLUSIONS: The results emphasize the importance of CAH as the most common diagnosis in 46XX cases presenting with ambiguous genitalia. Those with 46XY had a wider range of diagnoses. Despite thorough investigation, 23.5% had no definite final diagnosis made.